432430 — YLab Balance Sheet
0.000.00%
- KR₩80bn
- KR₩69bn
- KR₩25bn
Annual balance sheet for YLab, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | — | — | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 4,209 | 7,239 | 8,700 | 30,406 | 30,467 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 351 | 7,370 | 3,066 | 1,778 | 1,297 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 7,295 | 19,537 | 15,476 | 35,985 | 38,563 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2,444 | 1,961 | 1,790 | 4,853 | 8,109 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 12,218 | 24,361 | 19,363 | 46,290 | 54,063 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3,184 | 12,798 | 7,351 | 10,882 | 9,650 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 23,905 | 13,765 | 8,214 | 14,172 | 19,794 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | -11,687 | 10,596 | 11,148 | 32,118 | 34,269 |
| Total Liabilities & Shareholders' Equity | 12,218 | 24,361 | 19,363 | 46,290 | 54,063 |
| Total Common Shares Outstanding |